Publications

Type
Date
Drug Discovery
2021-05
InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-19
Author(s) Jonathan Fang, He-Ru Chen, Yunlong Tseng, Wan-Ni Yu, Tzung-Ju Wu, Yi-Chen Tsai, Tien-Tzu Tai, Sheue-Fang Shih, Keelung Hong; InspirMed, Inc., TLC Biopharmaceuticals Inc., Taiwan Liposome Company (TLC), Ltd.
Published
Drug Discovery
2020-07
A Strategy to Treat COVID-19 Disease with Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Non-clinical Pharmacokinetic Study
Author(s) Tien-Tzu Tai, Tzung-Ju Wu, Yi-Chen Tsai, Hui-Ting Wang, An-Min Wang and Sheue-Fang Shih; Taiwan Liposome Company (TLC), Ltd., Taipei, Taiwan
Published
Drug Discovery
2020-05
Single Intra-articular injection of TLC599 in Patients with Osteoarthritis Knee Pain: Subgroup Analyses of a Placebo-controlled 24-week Phase 2 Trial
Author(s)
Published
Drug Discovery
2020-02
The Pharmacokinetic and Pharmacodynamic Evaluation of Multilamellar Vesicles Formulated Ropivacaine, TLC590, Administered by Local Injection in Rats
Author(s) Yi-Yu Lin, Hao-Wen Kao, Walter Gwathney, Yunlong Tseng, Wan-Ni Yu, Keelung Hong
Published
Drug Discovery
2019-10
Magnetic Resonance Imaging of Knee Joint Protection Following an Intra-Articular Injection of Lipid-Based Dexamethasone Sodium Phosphate Sustained Release Formulation on Subjects with Knee Osteoarthritis
Author(s) Sheue-Fang Shih, Carl Brown, Tien-Tzu Tai and Wing Chuang; Taiwan Liposome Company (TLC), Ltd., Taipei, Taiwan
Published
Drug Discovery
2019-10
A Phase 1/2, Randomized, Double-blind, Comparator-controlled, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of TLC590 for Postsurgical Pain Management following Inguinal Hernia Repair
Author(s) Todd M. Bertoch, Carl O. Brown, Chih-Feng Wu, Pei-Hsien Hu, Tien-Tzu Tai, Weenee Y. N. Jao, Cheng-Yu Kuo, Hui-Ting Wang, Min-Wen, Kuo, Yun-Long Tseng, JBR Clinical Research, Salt Lake City, UT, USA and Taiwan Liposome Company (TLC), Taipei City, Taiwan
Published
Drug Discovery
2019-10
Formulation and Evaluation of Multilamellar Vesicles Ropivacaine in Pain Management
Author(s) Hao-Wen Kao, Yi-Yu Lin, Walter J Gwathney, Keelung Hong, TLC Biopharmaceuticals, Inc., South San Francisco, CA 94080, USA; Taiwan Liposome Company, Ltd., Taipei 11503, Taiwan
Published
Drug Discovery
2019-09
In Vivo Efficacy and Enhanced Tumor Accumulation of Liposomal Vinorelbine (TLC178) in Human Sarcoma Xenograft Mouse Models
Author(s) Wan-Ni. Yu, Jo-Hsin Tang, Tzung-Ju Wu, Yi-Chen Tsai and Hui-Ting Wang; Non-clinical Department, Pharmacokinetic Department, Taiwan Liposome Company, Taipei City, Taiwan
Published
Drug Discovery
2019-06
Pharmacokinetic and Toxicokinetic Studies of a Sustained Release Liposomal Formulation of Dexamethasone Sodium Phosphate (TLC599) Following Intra-articular Injection in Dogs
Author(s) Tzung-Ju Wu, Wan-Ni. Yu, Ming-Ju Wu, Po-Chun Chang, Hui-Ting Wang and Sheue-Fang Shih; Taiwan Liposome Company, Taipei, Taiwan
Published European Congress of Rheumatology (EULAR 2019)
Drug Discovery
2019-05
Cartilage Damage and Synovial Toxicokinetic Study of a Sustained Release Liposomal Formulation of Dexamethasone Sodium Phosphate (TLC599) following Intra-articular Injection in Healthy Dogs and Rabbits
Author(s) W-N. Yu, M-J Wu, P-C Chang, S-F Shih; Taiwan Liposome Company, Taipei, Taiwan
Published 2019 OARSI World Congress on Osteoarthritis
of
4
You are now leaving tlcbio.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

TLC provides this link as a service to website visitors. TLC is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click “Stay” or “X” to return to tlcbio.com or “Continue” to proceed.

Continue Stay